Table 2.

Univariate and multivariate analyses of the BRAF^V600E mutation and clinicopathological features in PTMC

Variable (n = 126)	Univariate analysis		Multivariate analysis
	OR (95% CI)	P-value	OR (95% CI)	P-value
Gender (male/female)	1.7 (0.3-8.9)	0.542	2.2 (0.3-13.9)	0.416
Age, yr (≥ 45 vs. < 45)	1.1 (0.4-2.6)	0.891	1.7 (0.6-4.6)	0.304
Tumar size, mm (5 < and ≤ 10 vs. ≤ 5)	1.7 (0.7-4.2)	0.283	1.4 (0.5-3.4)	0.494
Multifocality (multiple/single)	2.2 (0.2-20.9)	0.482	3.0 (0.3-33.2)	0.365
Extrathyroidal invasion (yes/no)	1.1 (0.1-12.4)	0.954	0.7 (0.1-9.7)	0.793
Hashimoto’s disease (yes/no)	0.5 (0.2-1.5)	0.244	0.6 (0.2-1.9)	0.396
LNM (yes/no)	3.1 (0.9-10.1)	0.057	3.7 (1.0-13.5)	0.045
T stage (T3/T1)	0.5 (0.1-8.7)	0.655	0.2 (0.01-5.1)	0.339

Note: Age and tumor size were assessed as continuous variables in both the univariate and multivariate analyses.